📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: AtheroGenics

1.1 - Company Overview

AtheroGenics Logo

AtheroGenics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pharmaceutical solutions focused on developing antioxidants.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to AtheroGenics

Corvia Medical Logo

Corvia Medical

HQ: United States Website
  • Description: Provider of transcatheter structural heart devices for heart failure, including the Corvia Atrial Shunt (InterAtrial Shunt Device) designed to treat diastolic heart failure/HFpEF by reducing pressures in the heart and lungs, supported by clinical evidence and the RESPONDER-HF clinical study assessing efficacy in patients with EF ≥40%.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Corvia Medical company profile →
Acron Genomics Logo

Acron Genomics

HQ: United Kingdom Website
  • Description: Provider of novel biotechnology platform development and commercialization in the life sciences, and of the introduction and development of promising new pharmaceutical compounds. U.S. publicly traded (OTC Markets/AGNM).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acron Genomics company profile →
Tactile Medical Logo

Tactile Medical

HQ: United States Website
  • Description: Provider of at-home medical devices and therapies for edema, lymphedema, and vascular and respiratory conditions, including Flexitouch Plus and Entre pneumatic compression systems, AffloVest mobile airway clearance therapy, Complete Decongestive Therapy, and patient education on lymphedema management.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tactile Medical company profile →
Ash Access Technology Logo

Ash Access Technology

HQ: United States Website
  • Description: Provider of technologies and devices to treat and prevent the clinical consequences of vascular access-related diseases, including central line hemodialysis catheters designed to prevent fibrous sheaths, split-tip dialysis catheters, 7% sodium citrate catheter lock solutions, an extracorporeal charcoal-based sorbent liver dialysis system, and skin prep for vascular access procedures.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ash Access Technology company profile →
InnAVasc Logo

InnAVasc

HQ: United States Website
  • Description: Provider of medical devices for vascular access in hemodialysis, focusing on immediate access, home hemodialysis, and dialysis needle protection; offering the InnAVasc Graft with protective backplates and self-sealing materials to prevent needle injuries and bleeding complications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InnAVasc company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for AtheroGenics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to AtheroGenics

2.2 - Growth funds investing in similar companies to AtheroGenics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for AtheroGenics

4.2 - Public trading comparable groups for AtheroGenics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to AtheroGenics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About AtheroGenics

What does AtheroGenics do?

AtheroGenics is a provider of pharmaceutical solutions focused on developing antioxidants.

Who are AtheroGenics's competitors?

AtheroGenics's competitors and similar companies include Corvia Medical, Acron Genomics, Tactile Medical, Ash Access Technology, and InnAVasc.

Where is AtheroGenics headquartered?

AtheroGenics is headquartered in United States.

How many employees does AtheroGenics have?

AtheroGenics has 1,000 employees 🔒.

When was AtheroGenics founded?

AtheroGenics was founded in 2010 🔒.

What sector and industry vertical is AtheroGenics in?

AtheroGenics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for AtheroGenics

Who are the top strategic acquirers in AtheroGenics's sector and industry

Top strategic M&A buyers and acquirers in AtheroGenics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for AtheroGenics?

Top strategic M&A buyers groups and sectors for AtheroGenics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in AtheroGenics's sector and industry vertical

Which are the top PE firms investing in AtheroGenics's sector and industry vertical?

Top PE firms investing in AtheroGenics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in AtheroGenics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in AtheroGenics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in AtheroGenics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to AtheroGenics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in AtheroGenics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for AtheroGenics?

The key public trading comparables and valuation benchmarks for AtheroGenics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for AtheroGenics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for AtheroGenics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in AtheroGenics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for AtheroGenics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in AtheroGenics's' sector and industry vertical?

Access recent funding rounds and capital raises in AtheroGenics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for AtheroGenics